Literature DB >> 34673402

Safety and recommendations for vaccinations of children with inborn errors of metabolism.

R Hady-Cohen1, P Dragoumi2, D Barca3, B Plecko4, T Lerman-Sagie1, D Zafeiriou5.   

Abstract

Inborn errors of metabolism (IEM) are genetic disorders due to a defective metabolic pathway. The incidence of each disorder is variable and depends on the respective population. Some disorders such as urea cycle disorders (UCD) and organic acidurias, pose a high risk for a metabolic crisis culminating in a life-threatening event, especially during infections; thus, vaccines may play a crucial role in prevention. However, there are different triggers for decompensations including the notion that vaccines themselves can activate fever and malaise. Additionally, many of the IEM include immunodeficiency, placing the patients at an increased risk for infectious diseases and possibly a weaker response to immunizations. Since metabolic crises and vaccine regimens intersect in the first years of life, the question whether to vaccinate the child occupies parents and medical staff. Many metabolic experts hesitate to vaccinate IEM patients, disregarding the higher risk from the direct infections. In this paper we summarize the published data regarding the safety and recommendations for vaccinations in IEM patients, with reference to the risk for decompensations and to the immunogenic component.
Copyright © 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decompensation; Immunodeficiency; Inborn errors of metabolism; Neurometabolic; Urea cycle disorder; Vaccination; Viruses

Mesh:

Year:  2021        PMID: 34673402     DOI: 10.1016/j.ejpn.2021.10.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  3 in total

1.  Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report.

Authors:  Silene M Silvera-Ruiz; Corinne Gemperle; Natalia Peano; Valentina Olivero; Adriana Becerra; Johannes Häberle; Adriana Gruppi; Laura E Larovere; Ruben D Motrich
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

2.  Safety of COVID-19 vaccines in children with inborn errors of metabolism in terms of developing metabolic decompensation.

Authors:  Tanyel Zubarioglu; Sinem Oral-Cebeci; Duhan Hopurcuoglu; Esma Uygur; Saffa Ahmadzada; Gözde Uzunyayla-Inci; Ece Oge-Enver; Sedanur Akca; Mirsaid Aghalarov; Gizem Yilmaz; Ertugrul Kiykim; Cigdem Aktuglu-Zeybek
Journal:  J Paediatr Child Health       Date:  2022-09-29       Impact factor: 1.929

3.  COVID-19 Vaccine in Inherited Metabolic Disorders Patients: A Cross-Sectional Study on Rate of Acceptance, Safety Profile and Effect on Disease.

Authors:  Albina Tummolo; Annamaria Dicintio; Giulia Paterno; Rosa Carella; Livio Melpignano; Donatella De Giovanni
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.